Health
Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab – The Lancet
Humoral and cell-mediated immune responses are blunted after SARS-CoV-2 vaccinationin patients with a history of CD20 B-cell-depleting…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
Continue Reading
